文献速递脊柱脊髓外科

巴罗创新中心病例系列:用于预防术中脊髓损伤的新型手术器械的早期临床经验

Barrow Innovation Center Case Series: Early Clinical Experience with Novel Surgical Instrument Used To Prevent Intraoperative Spinal Cord Injuries.
PubMed 文献 · World Neurosurg · 2018-08-27

巴罗创新中心通过住院医师创新培训项目,针对后路颈椎和胸椎手术中医源性脊髓损伤风险,经原型制作、尸体测试与重新设计的迭代流程开发出脊髓保护罩Myeloshield,并在6周内获得临时专利、用于手术室;2例病例报告显示其可在不阻碍手术流程的情况下使用,并具有预防医源性脊髓损伤的潜力。

要点

  • 后路颈椎和胸椎手术中医源性脊髓损伤风险升高,是该中心住院医师发现并着手解决的问题。
  • Myeloshield经原型制作、尸体测试与重新设计的迭代流程开发,6周内获临时专利并用于手术室。
  • 初步临床经验显示Myeloshield可在不阻碍手术流程的情况下使用,并具有预防医源性脊髓损伤的潜力。

核心结论

  • 巴罗创新中心这类项目可为神经外科住院医师提供医疗器械创新与知识产权开发的独特教育经历,并可成为手术质量改进和问题解决的途径。

研究设计与样本

  • 病例报告与创新项目描述:通过1例病例报告展示后路颈椎减压融合术中医源性脊髓损伤的风险,并由创新中心经原型制作、尸体测试和重新设计的迭代流程开发解决方案,由合作的专利法学生撰写并提交临时专利申请。
  • 初步临床经验通过2例病例报告展示Myeloshield在手术室中的使用。

主要发现

  • 开发出脊髓保护罩的概念,并在仅6周内获得临时专利并用于手术室,该器械被命名为Myeloshield。
  • 初步临床经验表明Myeloshield可在不阻碍手术流程的情况下使用,并具有预防医源性脊髓损伤的潜力。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Barrow Innovation Center comprises an educational program in medical innovation that enables residents to identify problems in patient care and rapidly develop and implement solutions to these problems. Residents involved in this program noted an elevated risk of iatrogenic spinal cord injury during posterior cervical and thoracic procedures. The objective of this study was to describe this complication, and a novel solution was developed through a new innovation training program. METHODS: A case report demonstrates the risk of iatrogenic spinal cord injury during posterior cervical decompression and fusion. Solutions to this problem were developed at the innovation center via an iterative process of prototype creation, cadaveric testing, and redesign. Patent law students who partnered with the center wrote and filed a provisional patent protecting the novel prototype designs. RESULTS: The concept of a protective shield for the spinal cord was developed, and within only 6 weeks the devices were provisionally patented and used in the operating room. This device was named the Myeloshield. Initial clinical experience indicates that the Myeloshield can be used without impeding the flow of surgery and has the potential to prevent iatrogenic spinal cord injury; this experience is presented through 2 case reports demonstrating the use of Myeloshields in the operating room. CONCLUSIONS: This report demonstrates how programs like the Barrow Innovation Center can provide neurosurgery residents with a unique educational experience in medical device innovation and intellectual property development and can serve as an avenue of surgical quality improvement and problem solving.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bohl MA, Baranoski JF, Sexton D, et al. Barrow Innovation Center Case Series: Early Clinical Experience with Novel Surgical Instrument Used To Prevent Intraoperative Spinal Cord Injuries. World Neurosurg. 2018. PMID: 30165209. doi:10.1016/j.wneu.2018.08.130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。